Alerts will be sent to your verified email
Verify Email
DRREDDY
|
Dr. Reddy's Lab
|
Mankind Pharma
|
Zydus Lifesciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
15.68 % | 20.33 % | 18.47 % |
|
5yr Avg Net Profit Margin
|
15.18 % | 17.68 % | 19.02 % |
|
Price to Book
|
3.18 | 7.25 | 4.16 |
|
P/E
|
18.81 | 54.93 | 21.8 |
|
5yr Avg Cash Conversion Cycle
|
74.48 Days | -13.08 Days | -84.89 Days |
|
5yr Average Interest Coverage Ratio
|
35.66 | 46.07 | 30.19 |
|
5yr Avg ROCE
|
21.82 % | 25.06 % | 19.65 % |
|
5yr Avg Operating Profit Margin
|
23.61 % | 24.62 % | 24.4 % |
|
5 yr average Debt to Equity
|
0.12 | 0.16 | 0.17 |
|
5yr CAGR Net Profit
|
23.71 % | 9.49 % | 16.23 % |
|
5yr Average Return on Assets
|
11.24 % | 14.46 % | 12.22 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
26.64 % | 72.68 % | 74.99 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.07 % | -3.82 % | 0.11 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.6 % | 5.51 % | 0.94 % |
|
Dr. Reddy's Lab
|
Mankind Pharma
|
Zydus Lifesciences
|
|---|